Global Ganja Report

A new day has dawned for medical marijuana patients in Argentina, who have finally won the right to home cultivation, three and a half years after medicinal use of cannabis derivatives was officially legalized in the South American country.

President Alberto Fernández on Nov. 12 signed a decree that had been issued by the Health Ministry earlier this year, stating: "It is imperative to create a regulatory framework that allows timely, inclusive and secure access for those who require to use cannabis as a therapeutic tool."

Cannabis industry leaders have announced certification standards to promote corporate responsibility. The move appears to be prompted by some embarrassing scandals in the young industry. Activists are meanwhile raising more far-reaching demands for drug war "reparations." 

Over the past two years, the Latin American cannabis industry has "emerged from the shadows" to command the attention of international firms and investors. Legal cannabis sales within the region are on track to reach $125 million in 2018—but that figure is expected to rise to $12.7 billion by 2028.

Around the world, mothers are on the frontlines of demanding legal access to cannabis products for their children who suffer from epilepsy and other ailments. Often, these courageous moms have risked their freedom to provide medicine for their offspring. Sometimes they have actually shamed the authorities into changing the law—but still face the prospect of prison time.

Oakland-based cannabis industry research firm ArcView Group has released a new study, ambitiously entitled "The Road Map to a $57 Billion Worldwide Market." It provides a sweeping overview of recent progress and future prospects for legal or medical herb across the globe. But it also warns that, due to continued legal restrictions and bureaucratic overstretch, the market is in most areas bottlenecked from achieving its potential.

The First Argentine Congress on Cannabis and Health was held last week at the National University of La Plata (UNLP), bringing together academics, activists, cultivators and patients from across the Southern Cone country. The focus was on expanding the extremely limited medical marijuana law passed in Argentina earlier this year. At the opening ceremony, held in an auditorium within La Plata's provinicial legislature building, UNLP president Raúl Perdomo pledged to "work to make the regulations for the recently approved law include the national universities in cultivation and research."

The medical marjuana advocacy organization Mamá Cultiva, which has been campaigning on the issue across South America, is criticizing the new measure just passed by Argentina's Senate for failing to legalize personal cultivation. The Senate voted unanimously on March 29 to legalize cannabis oil and other derivatives for medical purposes. Talking Drugs blog reports that the bill is set to become law immediately upon receiving President Mauricio Macri's signature, as it was already passed by the lower-house Chamber of Deputies in November. Under the law, patients must register with a planned national program to be overseen by the Ministry of Health.

After last year's victories for cannabis legalization measures in Colorado and Washington state, the US prohibition regime is under unprecedented pressure. But there is little awareness in Gringolandia of the strides in breaking with the US-led "war on drugs" in South America. Over the past decade, Argentina and Colombia have removed penalties for personal quantities of drugs, and Uruguay just passed a measure that essentially legalizes cannabis, with even cultivation permitted under state regulation. Venezuela, Bolivia and Ecuador have all barred the DEA from their territory.

That leaves Peru—now overtaking Colombia as the Andes' top coca producer, and also a burgeoning cannabis producer. Like Colombia, Peru remains a stronghold of the DEA in South America—even as it has moved towards decrim of personal quantities. Both countries have experienced long and bloody counterinsurgency wars related to the struggle for control over coca production. Much to Washington's displeasure, Peru even suspended eradication two years ago—before the empire struck back. But now activists are mounting pressure to break with the prohibition model—both in the remote campesino communities of the mountains and jungles, and in the streets of Lima.